Australia News
-
OECD: Australia has 527 biotech firms, ranks 6th
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Singapore: According to the Organisation for Economic Co-operation and Development's (OECD) directorate for Science, Technology and Industry statistics (updated until December 2011), Austra...Read more
-
Dr John Ballard: Angel of Australia biotech
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2012
Veterans in the life sciences industry in Australia distinguish Dr John Ballard as one of the founding and most significant leaders of the country's biotechnology industry. He is co-founder...Read more
-
AtCor Medical wins $3.2 mn contract
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2012
Singapore: AtCor Medical, developer and marketer of the SphygmoCor system which measures central aortic blood pressures and arterial stiffness non-invasively, has signed a contract to suppl...Read more
-
BioSA awards for Aussie innovators
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2013
Singapore: BioSA revealed that names of the awardees of the BioSA Bioscience Achievement Awards at its Welcome Reception for the AusBiotech Business Development Forum, held in Glenelg, Adel...Read more
-
iSonea updates its AsthmaSense app
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Dec, 2012
Singapore: Medical technology company iSonea has unveiled an updated version of its AsthmaSense asthma management smartphone app at a US mobile health conference. The updated version is e...Read more
-
Abraxane cancer trial shows positive results in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic melanoma study with Abraxane (nanoparticle albumin-bound paclitaxel) at...Read more
-
Aus govt gives Mesoblast $4.3 mn for stem cell work
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2013
Singapore: Mesoblast has received approximately $4.3 million under the Australian Government's Innovation Australia Research and Development (R &D) Tax Incentive Program for R&D act...Read more
-
Paul Ramsay leaves $3 bn to Ramsay Healthcare
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 May, 2014
Singapore: The founder of Ramsay Health Care, Mr Paul Ramsay breathed his last and even during his last moments left more than $3 billion to the foundation bearing his name. The 78-year-ol...Read more
-
Australia develops intelligent hi-res retinal camera
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: The Australian Government's Cooperative Research Center (CRC) Program is providing susbtantial amounts of funds to researchers in order to develop the Intelligent Retinal Camera ...Read more
-
IDT appoints Paul MacLeman as CEO
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2013
Singapore: IDT Australia appointed Dr Paul MacLeman as CEO, effective April 15, 2013. Dr MacLeman was recently the CEO of Melbourne-based biotechnology company Genetic Technologies, where h...Read more
-
Obese children more prone to Asthma: Study
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Researchers from the UK and Australia proved in a study that excess weight and obesity among children was a major reason contributing to Australia's high rates of asthma. The st...Read more
-
Dr Brian McNamee to step down from CSL
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2012
Singapore: After 23 years of being at the helm of CSL, Dr Brian McNamee will leave the firm in July 2013 and will be succeeded by Mr Paul Perreault, who is currently the president of CSL Be...Read more
-
Canada's investment giant enters Aus life science
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
On October 25, 2012, Canada-based international investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a high profile life sciences team. Canaccord Genu...Read more
-
Celgene's anti-cancer drug reactivates dormant HIV: Study
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: A study presented by Danish scientists at the AIDS 2014 conference, indicated that an anti-cancer drug made by US biotech firm Celgene could reactivate dormant HIV in patients, f...Read more
-
BioDiem expands antimicrobial profile
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agreement with Griffith University to expand the range of formulations of...Read more
-
Pharma companies set eyes on China
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more
-
Alchemia cancer trial gets nod from drug safety board
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's phase III, double blind, randomized, pivotal ...Read more
-
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more
